Lifeboat Foundation

We ask students to login via google as we share a lot of our content over google drive. To access the same, a google account is a must.

The CRISPR-Cas9 system has revolutionized genetic manipulations and made gene editing simpler, faster and easily accessible to most laboratories.

To its recognition, this year, the French-American duo Emmanuelle Charpentier and Jennifer Doudna have been awarded the prestigious Nobel Prize for chemistry for CRISPR.

Continue reading “[Burning Issue] CRISPR Technology and Associated Concerns” »

For the first time, a targeted gene replacement therapy has been approved in Canada, bringing hope to thousands of people struggling with a genetic condition in which their sight slowly degrades.

The research, out today from the University of Colorado Anschutz Medical Campus and published in * Evolution and Human Behavior*, presents a hypothesis supporting a role for fructose, a component of sugar and high fructose corn syrup, and uric acid (a fructose metabolite), in increasing the risk for these behavioral disorders.

Johnson outlines research that shows a foraging response stimulates risk taking, impulsivity, novelty seeking, rapid decision making, and aggressiveness to aid the securing of food as a survival response. Overactivation of this process from excess sugar intake may cause impulsive behavior that could range from ADHD, to bipolar disorder or even aggression.” “Johnson notes, “We do not blame aggressive behavior on sugar, but rather note that it may be one contributor.”” “The identification of fructose as a risk factor does not negate the importance of genetic, familial, physical, emotional and environmental factors that shape mental health,” he adds.

Huh, want to know more.

Continue reading “High fructose intake may drive aggressive behaviors, ADHD, bipolar” »

Summary: New artificial intelligence technology will analyze clinical data, brain images, and genetic information from Alzheimer’s patients to look for new biomarkers associated with the neurodegenerative disease.

Source: University of Pennsylvania

As the search for successful Alzheimer’s disease drugs remains elusive, experts believe that identifying biomarkers — early biological signs of the disease — could be key to solving the treatment conundrum. However, the rapid collection of data from tens of thousands of Alzheimer’s patients far exceeds the scientific community’s ability to make sense of it.

Controlling brains with light.

Thanks to optogenetics, in just ten years we’ve been able to artificially incept memories in mice, decipher brain signals that lead to pain, untangle the neural code for addiction, reverse depression, restore rudimentary sight in blinded mice, and overwrite terrible memories with happy ones. Optogenetics is akin to a universal programming language for the brain.

But it’s got two serious downfalls: it requires gene therapy, and it needs brain surgery to implant optical fibers into the brain.

Continue reading “Scientists Found a New Way to Control the Brain With Light—No Surgery Required” »

Mineral’s plant buggy looks like a platform on wheels, topped with solar panels and stuffed with cameras, sensors, and software.

But maybe there’s a better way—and Mineral wants to find it.

Like many things nowadays, the key to building something better is data. Genetic data, weather pattern data, soil composition and erosion data, satellite data… The list goes on. As part of the massive data-gathering that will need to be done, X introduced what it’s calling a “plant buggy” (if the term makes you picture a sort of baby stroller for plants, you’re not alone…).

Continue reading “Alphabet’s New Moonshot Is to Transform How We Grow Food” »

Researchers know how to make precise genetic changes within the genomes of crops, but the transformed cells often refuse to grow into plants. One team has devised a new solution.

Scientists who want to improve crops face a dilemma: it can be difficult to grow plants from cells after you’ve tweaked their genomes.

A new tool helps ease this process by coaxing the transformed cells, including those modified with the gene-editing system CRISPR-Cas9, to regenerate new plants. Howard Hughes Medical Institute Research Specialist Juan M. Debernardi and Investigator Jorge Dubcovsky, together with David Tricoli at the University of California, Davis Plant Transformation Facility, Javier Palatnik from Argentina, and colleagues at the John Innes Centre, collaborated on the work. The team reports the technology, developed in wheat and tested in other crops, October 12, 2020, in the journal Nature Biotechnology.

Continue reading “New Technology Accelerates Crop Improvement with CRISPR” »

Robots are now assisting in advancing developmental biology.

The study of developmental biology is getting a robotic helping hand.

Scientists are using a custom robot to survey how mutations in regulatory regions of the genome affect animal development. These regions aren’t genes, but rather stretches of DNA called enhancers that determine how genes are turned on and off during development. The team describes the findings—and the robot itself—on October 14 in the journal Nature.

Continue reading “Robots are helping to advance developmental biology” »

Analysis revealed that variants in the HMGCR gene region, which represent proxies for statin treatment, were associated with overall cancer risk, suggesting that statins could lower overall cancer risk.

Cholesterol-lowering drugs called statins may reduce cancer risk in humans through a pathway unrelated to cholesterol, says a study published today in eLife.

Statins reduce levels of LDL-cholesterol, the so-called ‘bad’ cholesterol, by inhibiting an enzyme called HMG-CoA-reductase (HMGCR). Clinical trials have previously demonstrated convincing evidence that statins reduce the risk of heart attacks and other cardiovascular diseases. But evidence for the potential effect of statins to reduce the risk of cancer is less clear.

Continue reading “Statins may reduce cancer risk through mechanisms separate to cholesterol” »